Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls

Comparison of follicular T helper cells, monocytes, and T cells priming between newly diagnosed and rituximab-treated MS patients and healthy controls

Background and purpose: The use of anti-CD20 monoclonal antibodies like rituximab (RTX) to deplete B cells has practical therapeutic implications in multiple sclerosis (MS) patients. However, the therapy’s impact on other immune cells is also important. Therefore, in this study, we assessed the effe...

Full description

Bibliographic Details
Main Authors: Sheida Yahyazadeh, Nafiseh Esmaeil, Vahid Shaygannejad, Omid Mirmosayyeb
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Research in Pharmaceutical Sciences
Subjects:
follicular; multiple sclerosis; rituximab; t cells priming; t helper cells
Online Access:http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2022;volume=17;issue=3;spage=315;epage=323;aulast=Yahyazadeh

Internet

http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2022;volume=17;issue=3;spage=315;epage=323;aulast=Yahyazadeh

Similar Items